| __timestamp | Ascendis Pharma A/S | BioCryst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19698000 | 51796000 |
| Thursday, January 1, 2015 | 40528000 | 72758000 |
| Friday, January 1, 2016 | 66022000 | 61008000 |
| Sunday, January 1, 2017 | 99589000 | 66962000 |
| Monday, January 1, 2018 | 140281000 | 84888000 |
| Tuesday, January 1, 2019 | 191621000 | 107068000 |
| Wednesday, January 1, 2020 | 260904000 | 122964000 |
| Friday, January 1, 2021 | 295867000 | 208808000 |
| Saturday, January 1, 2022 | 379624000 | 253297000 |
| Sunday, January 1, 2023 | 413454000 | 216566000 |
| Monday, January 1, 2024 | 307004000 |
In pursuit of knowledge
In the ever-evolving world of biotechnology, research and development (R&D) investments are the lifeblood of innovation. Over the past decade, Ascendis Pharma A/S and BioCryst Pharmaceuticals, Inc. have demonstrated a steadfast commitment to advancing medical science.
Since 2014, Ascendis Pharma A/S has increased its R&D spending by over 2,000%, reaching a peak in 2023. This remarkable growth underscores the company's dedication to pioneering new treatments and therapies.
BioCryst Pharmaceuticals, Inc. has also shown a robust increase in R&D investments, with a 300% rise from 2014 to 2023. This consistent growth highlights their focus on developing innovative solutions for rare diseases.
Both companies exemplify the biotech sector's relentless pursuit of breakthroughs, driving forward the future of healthcare.
R&D Spending Showdown: Alnylam Pharmaceuticals, Inc. vs Ascendis Pharma A/S
R&D Insights: How Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S Allocate Funds
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and BioCryst Pharmaceuticals, Inc.
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Ascendis Pharma A/S vs CRISPR Therapeutics AG: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and ImmunityBio, Inc.
Comparing Innovation Spending: Ascendis Pharma A/S and Mesoblast Limited
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Novavax, Inc.
R&D Insights: How Grifols, S.A. and BioCryst Pharmaceuticals, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Celldex Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.